MEC Practice Academy 11.19
|Articles|November 24, 2020

The high cost of diabetes medications: how patients cope

The soaring price of insulin and other diabetes-related medications has led many with the disease to adopt strategies for coping with the cost burden of controlling the disease.

The soaring price of insulin and other diabetes-related medications has led many with the disease to adopt strategies for coping with the cost burden of controlling the disease.A recent National Center for Health Statistics (NCHS) Data Brief finds that in 2018, 13% of adults with diabetes who’d been prescribed medications during the previous 12 months did not take them as prescribed, while 24% asked their doctor for less-costly medications. This is defined as skipping medication doses, taking less medicine than prescribed, or delaying refillsRead on for more details from the Data Brief.


Related to this article

AMA targets downcoding, AI licensure; Jacksonville pharmacy owner indicted in $51M fraud; drug-response gene variants found in every participant — Morning Medical Update © everythingpossible - stock.adobe.com
The top news stories in medicine today: The AMA moves against insurer downcoding and says AI can't be licensed as a physician; a Jacksonville pharmacy owner is indicted in a $51 million health care fraud scheme; an NIH study finds every participant carried a gene variant that can affect drug response.